AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimin MF 3mg/850mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Divine Savior Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (850mg)

Overview Glimin MF 3mg/850mg Tablet SR

Diabetic patients using Glimin MF 3mg/850mg SR tablets, a dual-action anti-diabetic medication, should be aware of its combined mechanism for managing type 2 diabetes in adults. This medication effectively regulates blood glucose, optimally administered with meals and consistently at the same time daily. Dosage adjustments, determined by your physician based on blood sugar monitoring, may be necessary. Continuous use, even with well-controlled blood sugar, is crucial; abrupt cessation can elevate blood glucose, potentially leading to complications like nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Remember, this medication complements a comprehensive diabetes management plan involving diet, exercise, and weight management as directed by your doctor. The most prevalent adverse effect is hypoglycemia (low blood sugar). Learn to identify symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures, such as readily available glucose sources (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be minimized. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is another potential consequence. Contraindications include type 1 diabetes, diabetic ketoacidosis, and significant hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests (complete blood count and liver function tests), are recommended as per your doctor's instructions.

Uses of Glimin MF 3mg/850mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimin MF 3mg/850mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet without crushing, chewing, or breaking it. Glimin MF 3mg/850mg Sustained-Release tablets should be administered with a meal.

Common Side effects of Glimin MF 3mg/850mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimin MF 3mg/850mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimin MF 3mg/850mg Tablet SR whole; do not alter its form by chewing, crushing, or breaking. Administer this medication with a meal.

How Glimin MF 3mg/850mg Tablet SR works:

Glimin MF 3mg/850mg Extended-Release tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimin MF 3mg/850mg Tablet SR with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimin MF 3mg/850mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Glimin MF 3mg/850mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimin MF 3mg/850mg Tablet SR to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician. The use of Glimin MF 3mg/850mg Tablet SR is contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimin MF 3mg/850mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. Low initial doses are typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimin MF 3mg/850mg Tablet SR :

Should you forget a Glimin MF 3mg/850mg Tablet SR dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimin MF 3mg/850mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glimin MF 3mg/850mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimin MF 3mg/850mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Glimin MF 3mg/850mg Tablet SR, if these symptoms occur.
Glimin MF 3mg/850mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimin MF 3mg/850mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimin MF 3mg/850mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimin MF 3mg/850mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol with Glimin MF 3mg/850mg Tablet SR is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimin MF 3mg/850mg Table...
57
MRP 70
18% off